Abstract
In order to realize long-term carrying/delivering oxygen and minimize the adverse effects of free hemoglobin (Hb) in vivo, Hb is desired to be confined in Hb-loaded nanoparticles (HbP), a novel blood substitute with potential clinical applications, and thus functions as the native red blood cells (RBCs). However, the initial burst release of Hb (“leaky effect”) greatly underscores the significance of this work. The study described here wants to disclose the key preparative parameters, including polymer, excipients in the inner aqueous phase and solvent profile, affecting the Hb release behavior (the initial 24 h) from HbP fabricated by commonly used solvent diffusion/evaporation double emulsion technique. The results demonstrate that PEGlytated polymers, regardless of two- or tri-block copolymers show slower release compared with the corresponding non-PEGlytated ones. The higher polymer concentration yields lower initial release. PEG200, added as excipient facilitates Hb burst effect to about 38.4%, almost 17% increase compared to the control (∼21%), whereas, PVA and Poloxamer188, due to amphiphilic nature, can effectively attenuate this leakage to about 13.0 and 5.1%, respectively. The diffusion/extraction rate from oil phase and the subsequent evaporation rate from the aqueous continuous phase of solvents impose different influences on Hb release. To reduce the burst effect, the initial diffusion/extraction rate should be slow, whereas, the concomitant evaporation rate should be as fast as possible. The results obtained here will be guidance’s for the future tailored design of more desirable polymersome nanoparticle blood substitutes.
Similar content being viewed by others
References
R.M. Winslow, Adv. Drug. Deliv. Rev. 40, 131 (2000)
C. Chauvierre, M.C. Marden, C. Vauthier, D. Labarre, P. Couvreur, L. Lecler, Biomaterials 25, 3081 (2004)
S.L. Li, J. Nickels, A.F. Palmer, Biomaterials 26, 3759 (2005)
V. Budhiraja, J.D. Hellums, Microvasc. Res. 64, 220 (2002)
T.M.S. Chang, J. Intern. Med. 253, 527 (2003)
F.T. Meng, G.H. Ma, Y.D. Liu, W. Qiu, Z.G. Su, Colloid Surf. B: Biointerf. 33, 177 (2004)
J. Zhao, C.S. Liu, Y. Yuan, X.Y. Tao, X.Q. Shan, Y. Sheng, F. Wu, Biomaterials 28, 1414 (2007)
A. Gabizon, D. Papahadjopoulos, Proc. Natl. Acad. Sci. 85, 6949 (1988)
N. Iodoshima, C. Udagawa, T. Ando, H. Fukuyasu, H. Watanabe, S. Nakabayashi, Int. J. Pharm. 146, 81 (1997)
C.D. Reiter, X.D. Wang, J.E. Tanus-Santos, N. Hogg, R.O. Cannon, A.N. Schechter, M.T. Gladwin, Nat. Med. 8, 1383 (2002)
R. Lee, K. Neya, T.A. Svizzero, G.J. Vlahakes, J. Appl. Physiol. 79, 236 (1995)
J.S. Olson, E.W. Foley, C. Rogge, A.L. Tsai, M.P. Doyle, D.D. Lemon, Free Radic. Biol. Med. 36, 685 (2004)
K. Sampei, J.A. Ulatowski, Y. Asano, H. Kwansa, E. Bucci, R.C. Koehler, Am. J. Physiol.: Heart Circ. Physiol. 289, H1191 (2005)
F.D. Cui, K. Shi, L.Q. Zhang, A.J. Tao, Y. Kawashima, J. Control Release 114, 242 (2006)
S. Ghosh, J. Chem. Res. 4, 241 (2004)
V. Coccoli, A. Luciani, S. Orsi, V. Guarino, F. Causa, P.A. Netti, J. Mater. Sci.: Mater. Med. doi:10.1007/S10856-007-3253-9
Y.Y. Yang, H.H. Chia, T.S. Chung, J. Control Release 69, 81 (2000)
J. Wang, B.M. Wang, S.P. Schwendeman, Biomaterials 25, 1919 (2004)
A.K. Bajpai, S. Bhanu, J. Mater. Sci.: Mater. Med. 18, 1613 (2007)
W.G. Zijlstra, A. Buursma, Comp. Biochem. Physiol. 118b, 743 (1997)
Y. Zhang, R.X. Zhuo, Biomaterials 26, 6736 (2005)
Z.P. Zhang, S.S. Feng, Biomaterials 27, 4025 (2006)
Y.P. Li, Y.Y. Pei, Z.H. Zhou, X.Y. Zhang, Z.H. Gu , J. Ding, J.J. Zhou, X.J. Gao, J. Control Release 71, 287 (2001)
D. Klose, F. Siepmann, K. Elkharraz, S. Krenzlin, J. Siepmann, Int. J. Pharm. 314, 198 (2006)
P. Johansen, Y. Men, R. Audran, G. Corradin, H.P. Merkle, B. Gander, Pharm. Res. 15, 1103 (1998)
Y.K. Katare, A.K. Pand, Eur. J. Pharm. Sci. 28, 179 (2006)
K.M. Shakesheff, C. Evora, I. Soriano, R. Langer, J. Colloid Interf. Sci. 185, 538 (1997)
C. Bouissou, J.J. Rouse, R. Price, C.F.V. Walle, Pharm. Res. 23, 1295 (2006)
F. Boury, T. Ivanova, I. Panaiotov, J.E. Proust, A. Bois, J. Richou, J. Colloid Interf. Sci. 169, 380 (1995)
L. Mu, S.S. Feng, J. Control Release 80, 129 (2002)
M.D. Blanco, M.J. Alonso, Eur. J. Pharm. Biopharm. 43, 287 (1997)
J.M. Péan, F. Boury, M.C. Venier-Julienne, P. Menei, J.E. Proust, J.P. Benoit, Pharm. Res. 16, 1294 (1999)
T. Sato, M. Kanke, H.G. Schroeder, P.P. Deluca, Pharm. Res. 5, 21 (1988)
Y.Y. Yang, T.S. Chung, X.L. Bai, W.K. Chan, Chem. Eng. Sci. 55, 2223 (2000)
X.S. Luan, M. Skupin, J. Siepmann, Int. J. Pharm. 324, 168 (2006)
T.W. Chung, Y.Y. Huang, Y.Z. Liu, Int. J. Pharm. 212, 161 (2001)
Y.Y. Yang, H.H. Chia, T.S. Chung, J. Control Release 69, 81 (2000)
Acknowledgements
The authors appreciate the financial support from the National High Technology Research and Development Program of China (863 Program) (No. 2004AA-302050) and from Shanghai Nanotechnology Special Foundation (No. 0452nm022).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhang, X., Liu, C., Yuan, Y. et al. Key parameters affecting the initial leaky effect of hemoglobin-loaded nanoparticles as blood substitutes. J Mater Sci: Mater Med 19, 2463–2470 (2008). https://doi.org/10.1007/s10856-007-3358-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10856-007-3358-1